{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:11:47Z","timestamp":1778944307330,"version":"3.51.4"},"publisher-location":"Cham","reference-count":304,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032005366","type":"print"},{"value":"9783032005373","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-032-00537-3_4","type":"book-chapter","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T05:50:25Z","timestamp":1758865825000},"page":"65-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetics and cancer-related Laminopathies: Involvement of Lamins and Lamin-Chromatin Interactions"],"prefix":"10.1007","author":[{"given":"Camille","family":"Desgrouas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Bonello-Palot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annachiara","family":"De Sandre-Giovannoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Roll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Kaspi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Badens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"4_CR1","doi-asserted-by":"crossref","unstructured":"Bonne G, Barletta MRD, Varnous S et al (1999) Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21:285\u2013288","DOI":"10.1038\/6799"},{"key":"4_CR2","doi-asserted-by":"crossref","unstructured":"Fatkin D, MacRae C, Sasaki T et al (1999) Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341:1715\u20131724","DOI":"10.1056\/NEJM199912023412302"},{"key":"4_CR3","doi-asserted-by":"crossref","unstructured":"Maggi L, Carboni N, Bernasconi P (2016) Skeletal muscle laminopathies: a review of clinical and molecular features. Cells 5:33","DOI":"10.3390\/cells5030033"},{"key":"4_CR4","volume-title":"GeneReviews\u00ae","author":"G Bonne","year":"1993","unstructured":"Bonne G, Leturcq F, Ben Yaou R (1993) Emery-Dreifuss muscular dystrophy. In: Adam MP, Feldman J, Mirzaa GM et al (eds) GeneReviews\u00ae. University of Washington, Seattle, WA"},{"key":"4_CR5","doi-asserted-by":"crossref","unstructured":"Maggi L, Mavroidis M, Psarras S et al (2021) Skeletal and cardiac muscle disorders caused by mutations in genes encoding intermediate filament proteins. Int J Mol Sci 22:4256","DOI":"10.3390\/ijms22084256"},{"key":"4_CR6","doi-asserted-by":"crossref","unstructured":"Rosenbaum AN, Agre KE, Pereira NL (2020) Genetics of dilated cardiomyopathy: practical implications for heart failure management. Nat Rev Cardiol 17:286\u2013297","DOI":"10.1038\/s41569-019-0284-0"},{"key":"4_CR7","doi-asserted-by":"crossref","unstructured":"Richard P, Fressart V, Charron P, Hainque B (2010) Genetics of inherited cardiomyopathies. Pathol Biol (Paris) 58:343\u2013352","DOI":"10.1016\/j.patbio.2009.10.010"},{"key":"4_CR8","doi-asserted-by":"crossref","unstructured":"Japp AG, Gulati A, Cook SA et al (2016) The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol 67:2996\u20133010","DOI":"10.1016\/j.jacc.2016.03.590"},{"key":"4_CR9","doi-asserted-by":"crossref","unstructured":"Ditaranto R, Boriani G, Biffi M et al (2019) Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset. Orphanet J Rare Dis 14:263","DOI":"10.1186\/s13023-019-1245-8"},{"key":"4_CR10","doi-asserted-by":"crossref","unstructured":"Cattin M, Muchir A, Bonne G (2013) \u2018state-of-the-heart\u2019 of cardiac laminopathies. Curr Opin Cardiol 28:297\u2013304","DOI":"10.1097\/HCO.0b013e32835f0c79"},{"key":"4_CR11","doi-asserted-by":"crossref","unstructured":"Storey EC, Fuller HR (2022) Genotype-phenotype correlations in human diseases caused by mutations of LINC complex-associated genes: a systematic review and meta-summary. Cells 11:4065","DOI":"10.3390\/cells11244065"},{"key":"4_CR12","doi-asserted-by":"crossref","unstructured":"Tesson F, Saj M, Uvaize MM et al (2014) Lamin A\/C mutations in dilated cardiomyopathy. Cardiol J 21:331\u2013342","DOI":"10.5603\/CJ.a2014.0037"},{"key":"4_CR13","doi-asserted-by":"crossref","unstructured":"Jakobs PM, Hanson EL, Crispell KA et al (2001) Novel lamin A\/C mutations in two families with dilated cardiomyopathy and conduction system disease. J Card Fail 7:249\u2013256","DOI":"10.1054\/jcaf.2001.26339"},{"key":"4_CR14","doi-asserted-by":"crossref","unstructured":"Dittmer TA, Sahni N, Kubben N et al (2014) Systematic identification of pathological lamin A interactors. Mol Biol Cell 25:1493\u20131510","DOI":"10.1091\/mbc.e14-02-0733"},{"key":"4_CR15","doi-asserted-by":"crossref","unstructured":"Zahr HC, Jaalouk DE (2018) Exploring the crosstalk between LMNA and splicing machinery gene mutations in dilated cardiomyopathy. Front Genet 9:231","DOI":"10.3389\/fgene.2018.00231"},{"key":"4_CR16","doi-asserted-by":"crossref","unstructured":"Nishiuchi S, Makiyama T, Aiba T et al (2017) Gene-based risk stratification for cardiac disorders in LMNA mutation carriers. Circ Cardiovasc Genet 10:e001603","DOI":"10.1161\/CIRCGENETICS.116.001603"},{"key":"4_CR17","doi-asserted-by":"crossref","unstructured":"Brull A, Morales Rodriguez B, Bonne G et al (2018) The pathogenesis and therapies of striated muscle laminopathies. Front Physiol 9:1533","DOI":"10.3389\/fphys.2018.01533"},{"key":"4_CR18","doi-asserted-by":"crossref","unstructured":"Chatzifrangkeskou M, Le Dour C, Muchir A (2023) Modulation of cytoskeleton in cardiomyopathy caused by mutations in LMNA gene. Am J Physiol Cell Physiol 324:C1223\u2013C1235","DOI":"10.1152\/ajpcell.00471.2022"},{"key":"4_CR19","doi-asserted-by":"crossref","unstructured":"Leong EL, Khaing NT, Cadot B et al (2023) Nesprin-1 LINC complexes recruit microtubule cytoskeleton proteins and drive pathology in Lmna-mutant striated muscle. Hum Mol Genet 32:177\u2013191","DOI":"10.1093\/hmg\/ddac179"},{"key":"4_CR20","first-page":"557","volume-title":"Methods in enzymology","author":"A Muchir","year":"2016","unstructured":"Muchir A, Worman HJ (2016) Targeting mitogen-activated protein kinase signaling in mouse models of cardiomyopathy caused by Lamin A\/C gene mutations. In: Methods in enzymology. Elsevier, pp 557\u2013580"},{"key":"4_CR21","doi-asserted-by":"crossref","unstructured":"Arimura T, Helbling-Leclerc A, Massart C et al (2005) Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet 14:155\u2013169","DOI":"10.1093\/hmg\/ddi017"},{"key":"4_CR22","doi-asserted-by":"crossref","unstructured":"Mounkes LC, Kozlov SV, Rottman JN, Stewart CL (2005) Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum Mol Genet 14:2167\u20132180","DOI":"10.1093\/hmg\/ddi221"},{"key":"4_CR23","doi-asserted-by":"crossref","unstructured":"Chai RJ, Werner H, Li PY et al (2021) Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy. Nat Commun 12:4722","DOI":"10.1038\/s41467-021-24849-4"},{"key":"4_CR24","doi-asserted-by":"crossref","unstructured":"Tan CY, Chan PS, Tan H et al (2023) Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity. J Transl Med 21:690","DOI":"10.1186\/s12967-023-04542-4"},{"key":"4_CR25","doi-asserted-by":"crossref","unstructured":"Ho JCY, Zhou T, Lai W-H et al (2011) Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A\/C. Aging (Albany NY) 3:380\u2013390","DOI":"10.18632\/aging.100277"},{"key":"4_CR26","doi-asserted-by":"crossref","unstructured":"Lee Y-K, Lau Y-M, Cai Z-J et al (2017) Modeling treatment response for lamin A\/C related dilated cardiomyopathy in human induced pluripotent stem cells. J Am Heart Assoc 6:e005677","DOI":"10.1161\/JAHA.117.005677"},{"key":"4_CR27","doi-asserted-by":"crossref","unstructured":"Bertero A, Fields PA, Smith AST et al (2019) Chromatin compartment dynamics in a haploinsufficient model of cardiac laminopathy. J Cell Biol 218:2919\u20132944","DOI":"10.1083\/jcb.201902117"},{"key":"4_CR28","doi-asserted-by":"crossref","unstructured":"Salvarani N, Crasto S, Miragoli M et al (2019) The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy. Nat Commun 10:2267","DOI":"10.1038\/s41467-019-09929-w"},{"key":"4_CR29","doi-asserted-by":"crossref","unstructured":"Captur G, Arbustini E, Bonne G et al (2018) Lamin and the heart. Heart 104:468\u2013479","DOI":"10.1136\/heartjnl-2017-312338"},{"key":"4_CR30","doi-asserted-by":"crossref","unstructured":"Kumar S, Baldinger SH, Gandjbakhch E et al (2016) Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers. J Am Coll Cardiol 68:2299\u20132307","DOI":"10.1016\/j.jacc.2016.08.058"},{"key":"4_CR31","doi-asserted-by":"crossref","unstructured":"Benarroch L, Cohen E, Atalaia A et al (2021) Preclinical advances of therapies for laminopathies. J Clin Med 10:4834","DOI":"10.3390\/jcm10214834"},{"key":"4_CR32","doi-asserted-by":"crossref","unstructured":"Mosbah H, Donadille B, Vatier C et al (2022) Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins). Orphanet J Rare Dis 17:170","DOI":"10.1186\/s13023-022-02308-7"},{"key":"4_CR33","first-page":"33","volume":"43","author":"MG Dunnigan","year":"1974","unstructured":"Dunnigan MG, Cochrane MA, Kelly A, Scott JW (1974) Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q J Med 43:33\u201348","journal-title":"Q J Med"},{"key":"4_CR34","doi-asserted-by":"crossref","unstructured":"Gonzaga-Jauregui C, Ge W, Staples J et al (2020) Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care Cohort. Diabetes 69:249\u2013258","DOI":"10.2337\/db19-0447"},{"key":"4_CR35","doi-asserted-by":"crossref","unstructured":"Fernandez-Pombo A, Diaz-Lopez EJ, Castro AI et al (2023) Clinical spectrum of LMNA-associated type 2 familial partial lipodystrophy: a systematic review. Cells 12","DOI":"10.3390\/cells12050725"},{"key":"4_CR36","doi-asserted-by":"crossref","unstructured":"Guill\u00edn-Amarelle C, Fern\u00e1ndez-Pombo A, S\u00e1nchez-Iglesias S, Ara\u00fajo-Vilar D (2018) Lipodystrophic laminopathies: diagnostic clues. Nucleus 9:249\u2013260","DOI":"10.1080\/19491034.2018.1454167"},{"key":"4_CR37","doi-asserted-by":"crossref","unstructured":"Krimm I, \u00d6stlund C, Gilquin B et al (2002) The Ig-like structure of the C-terminal domain of lamin A\/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure 10:811\u2013823","DOI":"10.1016\/S0969-2126(02)00777-3"},{"key":"4_CR38","doi-asserted-by":"crossref","unstructured":"Cao H (2000) Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 9:109\u2013112","DOI":"10.1093\/hmg\/9.1.109"},{"key":"4_CR39","doi-asserted-by":"crossref","unstructured":"Speckman RA, Garg A, Du F et al (2000) Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of Lamin A\/C. Am J Hum Genet 66:1192\u20131198","DOI":"10.1086\/302836"},{"key":"4_CR40","doi-asserted-by":"crossref","unstructured":"Schmidt HH-J, Genschel J, Baier P et al (2001) Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J Clin Endocrinol Metabol 86:2289\u20132295","DOI":"10.1210\/jcem.86.5.7500"},{"key":"4_CR41","doi-asserted-by":"crossref","unstructured":"Shackleton S, Lloyd DJ, Jackson SNJ et al (2000) LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy. Nat Genet 24:153\u2013156","DOI":"10.1038\/72807"},{"key":"4_CR42","doi-asserted-by":"crossref","unstructured":"Vigouroux C, Magr\u00e9 J, Vantyghem MC et al (2000) Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes 49:1958\u20131962","DOI":"10.2337\/diabetes.49.11.1958"},{"key":"4_CR43","doi-asserted-by":"crossref","unstructured":"Lanktree M, Cao H, Rabkin S et al (2007) Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660). Clin Genet 71:183\u2013186","DOI":"10.1111\/j.1399-0004.2007.00740.x"},{"key":"4_CR44","doi-asserted-by":"crossref","unstructured":"Gu\u00e9nantin AC, Briand N, Bidault G et al (2014) Nuclear envelope-related lipodystrophies. Semin Cell Dev Biol 29:148\u2013157","DOI":"10.1016\/j.semcdb.2013.12.015"},{"key":"4_CR45","doi-asserted-by":"crossref","unstructured":"Araujo-Vilar D, Lattanzi G, Gonzalez-Mendez B et al (2008) Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy. J Med Genet 46:40\u201348","DOI":"10.1136\/jmg.2008.059485"},{"key":"4_CR46","doi-asserted-by":"crossref","unstructured":"Pellegrini C, Columbaro M, Schena E et al (2019) Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning. Exp Mol Med 51:1\u201317","DOI":"10.1038\/s12276-019-0289-0"},{"key":"4_CR47","doi-asserted-by":"crossref","unstructured":"Capanni C, Mattioli E, Columbaro M et al (2005) Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. Hum Mol Genet 14:1489\u20131502","DOI":"10.1093\/hmg\/ddi158"},{"key":"4_CR48","doi-asserted-by":"crossref","unstructured":"Varlet A-A, Desgrouas C, Jebane C et al (2021) A rare mutation in LMNB2 associated with lipodystrophy drives premature cell senescence. Cells 11:50","DOI":"10.3390\/cells11010050"},{"key":"4_CR49","doi-asserted-by":"crossref","unstructured":"Vigouroux C, Gu\u00e9nantin A-C, Vatier C et al (2018) Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives. Nucleus 9:235\u2013248","DOI":"10.1080\/19491034.2018.1456217"},{"key":"4_CR50","doi-asserted-by":"crossref","unstructured":"Perepelina K, Dmitrieva R, Ignatieva E et al (2018) Lamin A\/C mutation associated with lipodystrophy influences adipogenic differentiation of stem cells through interaction with Notch signaling. Biochem Cell Biol 96:342\u2013348","DOI":"10.1139\/bcb-2017-0210"},{"key":"4_CR51","doi-asserted-by":"crossref","unstructured":"Simon DN, Domaradzki T, Hofmann WA, Wilson KL (2013) Lamin A tail modification by SUMO1 is disrupted by familial partial lipodystrophy\u2013causing mutations. MBoC 24:342\u2013350","DOI":"10.1091\/mbc.e12-07-0527"},{"key":"4_CR52","doi-asserted-by":"crossref","unstructured":"Jebane C, Varlet A-A, Karnat M et al (2023) Enhanced cell viscosity: a new phenotype associated with lamin A\/C alterations. iScience 26:107714","DOI":"10.1016\/j.isci.2023.107714"},{"key":"4_CR53","volume-title":"StatPearls","author":"K Quinn","year":"2023","unstructured":"Quinn K, Chauhan S, Purcell SM (2023) Lipodystrophies. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"4_CR54","doi-asserted-by":"crossref","unstructured":"Foss-Freitas MC, Besci \u00d6, Meral R et al (2023) A very-low-calorie diet can cause remission of diabetes mellitus and hypertriglyceridemia in familial partial lipodystrophy. Obes Facts 1\u20136:103","DOI":"10.1159\/000533992"},{"key":"4_CR55","doi-asserted-by":"crossref","unstructured":"Semple RK, Patel KA, Auh S et al (2023) Genotype-stratified treatment for monogenic insulin resistance: a systematic review. Commun Med 3:134","DOI":"10.1101\/2023.04.17.23288671"},{"key":"4_CR56","doi-asserted-by":"crossref","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT et al (2016) The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metabol 101:4500\u20134511","DOI":"10.1210\/jc.2016-2466"},{"key":"4_CR57","doi-asserted-by":"crossref","unstructured":"Garg A, Vinaitheerthan M, Weatherall PT, Bowcock AM (2001) Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a\/c gene. J Clin Endocrinol Metab 86:59\u201365","DOI":"10.1210\/jc.86.1.59"},{"key":"4_CR58","doi-asserted-by":"crossref","unstructured":"Soyaltin UE, Simsir IY, Akinci B et al (2020) Homozygous LMNA p.R582H pathogenic variant reveals increasing effect on the severity of fat loss in lipodystrophy. Clin Diabetes Endocrinol 6:13","DOI":"10.1186\/s40842-020-00100-9"},{"key":"4_CR59","doi-asserted-by":"crossref","unstructured":"Dutour A, Roll P, Gaborit B et al (2011) High prevalence of laminopathies among patients with metabolic syndrome. Hum Mol Genet 20:3779\u20133786","DOI":"10.1093\/hmg\/ddr294"},{"key":"4_CR60","doi-asserted-by":"crossref","unstructured":"Desgrouas C, Varlet A-A, Dutour A et al (2020) Unraveling LMNA mutations in metabolic syndrome: cellular phenotype and clinical pitfalls. Cells 9:310","DOI":"10.3390\/cells9020310"},{"key":"4_CR61","doi-asserted-by":"crossref","unstructured":"H\u00f6ger TH, Krohne G, Kleinschmidt JA (1991) Interaction of Xenopus lamins A and LII with chromatin in vitro mediated by a sequence element in the carboxyterminal domain. Exp Cell Res 197:280\u2013289","DOI":"10.1016\/0014-4827(91)90434-V"},{"key":"4_CR62","doi-asserted-by":"crossref","unstructured":"Decaudain A, Vantyghem M-C, Guerci B et al (2007) New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metabol 92:4835\u20134844","DOI":"10.1210\/jc.2007-0654"},{"key":"4_CR63","doi-asserted-by":"crossref","unstructured":"Le Dour C, Schneebeli S, Bakiri F et al (2011) A homozygous mutation of prelamin-A preventing its farnesylation and maturation leads to a severe lipodystrophic phenotype: new insights into the pathogenicity of nonfarnesylated prelamin-A. J Clin Endocrinol Metabol 96:E856\u2013E862","DOI":"10.1210\/jc.2010-2234"},{"key":"4_CR64","doi-asserted-by":"crossref","unstructured":"Galant D, Gaborit B, Desgrouas C et al (2016) A heterozygous ZMPSTE24 mutation associated with severe metabolic syndrome, ectopic fat accumulation, and dilated cardiomyopathy. Cells 5:21","DOI":"10.3390\/cells5020021"},{"key":"4_CR65","doi-asserted-by":"crossref","unstructured":"Skre H (1974) Genetic and clinical aspects of Charcot-Marie-Tooth\u2019s disease. Clin Genet 6:98\u2013118","DOI":"10.1111\/j.1399-0004.1974.tb00638.x"},{"key":"4_CR66","doi-asserted-by":"crossref","unstructured":"Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259\u2013280","DOI":"10.1093\/brain\/103.2.259"},{"key":"4_CR67","doi-asserted-by":"crossref","unstructured":"Bacquet J, Stojkovic T, Boyer A et al (2018) Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation. BMJ Open 8:e021632","DOI":"10.1136\/bmjopen-2018-021632"},{"key":"4_CR68","unstructured":"Roa BB, Garcia CA, Lupski JR (1991) Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy. Int J Neurol 25\u201326:97\u2013107"},{"key":"4_CR69","doi-asserted-by":"crossref","unstructured":"De Sandre-Giovannoli A, Chaouch M, Kozlov S et al (2002) Homozygous defects in LMNA, encoding lamin A\/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 70:726\u2013736","DOI":"10.1086\/339274"},{"key":"4_CR70","doi-asserted-by":"crossref","unstructured":"Chaouch M, Allal Y, De Sandre-Giovannoli A et al (2003) The phenotypic manifestations of autosomal recessive axonal Charcot\u2013Marie\u2013Tooth due to a mutation in Lamin A\/C gene. Neuromuscul Disord 13:60\u201367","DOI":"10.1016\/S0960-8966(02)00196-7"},{"key":"4_CR71","doi-asserted-by":"crossref","unstructured":"Tazir M (2004) Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A\/C. Brain 127:154\u2013163","DOI":"10.1093\/brain\/awh021"},{"key":"4_CR72","doi-asserted-by":"crossref","unstructured":"Goizet C, Yaou RB, Demay L et al (2004) A new mutation of the lamin A\/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia. J Med Genet 41:e29","DOI":"10.1136\/jmg.2003.013383"},{"key":"4_CR73","doi-asserted-by":"crossref","unstructured":"Benedetti S, Bertini E, Iannaccone S et al (2005) Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy. J Neurol Neurosurg Psychiatry 76:1019\u20131021","DOI":"10.1136\/jnnp.2004.046110"},{"key":"4_CR74","doi-asserted-by":"crossref","unstructured":"Walter MC, Witt TN, Weigel BS et al (2005) Deletion of the LMNA initiator codon leading to a neurogenic variant of autosomal dominant Emery-Dreifuss muscular dystrophy. Neuromuscul Disord 15:40\u201344","DOI":"10.1016\/j.nmd.2004.09.007"},{"key":"4_CR75","doi-asserted-by":"crossref","unstructured":"Bouhouche A, Birouk N, Azzedine H et al (2007) Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families. Brain 130:1062\u20131075","DOI":"10.1093\/brain\/awm014"},{"key":"4_CR76","doi-asserted-by":"crossref","unstructured":"Hamadouche T, Poitelon Y, Genin E et al (2008) Founder effect and estimation of the age of the c.892C>T (p.Arg298Cys) mutation in LMNA associated to charcot-marie-tooth subtype CMT2B1 in families from North Western Africa. Ann Hum Genet 72:590\u2013597","DOI":"10.1111\/j.1469-1809.2008.00456.x"},{"key":"4_CR77","doi-asserted-by":"crossref","unstructured":"Lassuthov\u00e1 P, Bar\u00e1nkov\u00e1 L, Haberlov\u00e1 J et al (2009) Mutations in the LMNA gene do not cause axonal CMT in Czech patients. J Hum Genet 54:365\u2013368","DOI":"10.1038\/jhg.2009.43"},{"key":"4_CR78","unstructured":"Song S, Zhang Y, Chen B et al (2006) No mutation was detected in the LMNA gene among sporadic Charcot-Marie-Tooth patients. Beijing Da Xue Xue Bao 38:78\u201379"},{"issue":"17\u201346","key":"4_CR79","first-page":"25","volume":"80","author":"H Gilford","year":"1897","unstructured":"Gilford H (1897) On a condition of mixed premature and immature development. Med Chir Trans 80(17\u201346):25","journal-title":"Med Chir Trans"},{"key":"4_CR80","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/095952878606900127","volume":"69","author":"J Hutchinson","year":"1886","unstructured":"Hutchinson J (1886) Congenital absence of hair and mammary glands with atrophic condition of the skin and its appendages, in a boy whose mother had been almost wholly bald from alopecia areata from the age of six. Med Chir Trans 69:473\u2013477","journal-title":"Med Chir Trans"},{"key":"4_CR81","doi-asserted-by":"crossref","unstructured":"Ullrich NJ, Gordon LB (2015) Hutchinson-Gilford progeria syndrome. Handb Clin Neurol 132:249\u2013264","DOI":"10.1016\/B978-0-444-62702-5.00018-4"},{"key":"4_CR82","doi-asserted-by":"crossref","unstructured":"Gordon CM, Cleveland RH, Baltrusaitis K et al (2019) Extraskeletal calcifications in Hutchinson-Gilford progeria syndrome. Bone 125:103\u2013111","DOI":"10.1016\/j.bone.2019.05.008"},{"key":"4_CR83","doi-asserted-by":"crossref","unstructured":"Murtada S-I, Kawamura Y, Cavinato C et al (2023) Biomechanical and transcriptional evidence that smooth muscle cell death drives an osteochondrogenic phenotype and severe proximal vascular disease in progeria. Biomech Model Mechanobiol 22:1333\u20131347","DOI":"10.1007\/s10237-023-01722-5"},{"key":"4_CR84","doi-asserted-by":"crossref","unstructured":"Stehbens WE, Wakefield SJ, Gilbert-Barness E et al (1999) Histological and ultrastructural features of atherosclerosis in progeria. Cardiovasc Pathol 8:29\u201339","DOI":"10.1016\/S1054-8807(98)00023-4"},{"key":"4_CR85","doi-asserted-by":"crossref","unstructured":"Benedicto I, Dorado B, Andr\u00e9s V (2021) Molecular and cellular mechanisms driving cardiovascular disease in Hutchinson-Gilford progeria syndrome: lessons learned from animal models. Cells 10:1157","DOI":"10.3390\/cells10051157"},{"key":"4_CR86","doi-asserted-by":"crossref","unstructured":"Olsen FJ, Gordon LB, Smoot L et al (2023) Progression of cardiac abnormalities in Hutchinson-Gilford progeria syndrome: a prospective longitudinal study. Circulation 147:1782\u20131784","DOI":"10.1161\/CIRCULATIONAHA.123.064370"},{"key":"4_CR87","doi-asserted-by":"crossref","unstructured":"Prakash A, Gordon LB, Kleinman ME et al (2018) Cardiac abnormalities in patients with Hutchinson-Gilford progeria syndrome. JAMA Cardiol 3:326\u2013334","DOI":"10.1001\/jamacardio.2017.5235"},{"key":"4_CR88","doi-asserted-by":"crossref","unstructured":"Hennekam RCM (2006) Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A 140:2603\u20132624","DOI":"10.1002\/ajmg.a.31346"},{"key":"4_CR89","doi-asserted-by":"crossref","unstructured":"De Sandre-Giovannoli A, Bernard R, Cau P et al (2003) Lamin a truncation in Hutchinson-Gilford progeria. Science 300:2055","DOI":"10.1126\/science.1084125"},{"key":"4_CR90","doi-asserted-by":"crossref","unstructured":"Eriksson M, Brown WT, Gordon LB et al (2003) Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome. Nature 423:293\u2013298","DOI":"10.1038\/nature01629"},{"key":"4_CR91","doi-asserted-by":"crossref","unstructured":"Cau P, Navarro C, Harhouri K et al (2014) Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective. Semin Cell Dev Biol 29:125\u2013147","DOI":"10.1016\/j.semcdb.2014.03.021"},{"key":"4_CR92","doi-asserted-by":"crossref","unstructured":"Goldman RD, Shumaker DK, Erdos MR et al (2004) Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 101:8963\u20138968","DOI":"10.1073\/pnas.0402943101"},{"key":"4_CR93","doi-asserted-by":"crossref","unstructured":"R\u00f6hrl JM, Arnold R, Djabali K (2021) Nuclear pore complexes cluster in dysmorphic nuclei of normal and progeria cells during replicative senescence. Cells 10:153","DOI":"10.3390\/cells10010153"},{"key":"4_CR94","doi-asserted-by":"crossref","unstructured":"Chen Z-J, Wang W-P, Chen Y-C et al (2014) Dysregulated interactions between lamin A and SUN1 induce abnormalities in the nuclear envelope and endoplasmic reticulum in progeric laminopathies. J Cell Sci 127:1792\u20131804","DOI":"10.1242\/jcs.139683"},{"key":"4_CR95","doi-asserted-by":"crossref","unstructured":"Chojnowski A, Ong PF, Foo MXR et al (2020) Heterochromatin loss as a determinant of progerin-induced DNA damage in Hutchinson-Gilford Progeria. Aging Cell 19:e13108","DOI":"10.1111\/acel.13108"},{"key":"4_CR96","doi-asserted-by":"crossref","unstructured":"Scaffidi P, Misteli T (2006) Lamin A-dependent nuclear defects in human aging. Science 312:1059\u20131063","DOI":"10.1126\/science.1127168"},{"key":"4_CR97","doi-asserted-by":"crossref","unstructured":"Shumaker DK, Dechat T, Kohlmaier A et al (2006) Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc Natl Acad Sci USA 103:8703\u20138708","DOI":"10.1073\/pnas.0602569103"},{"key":"4_CR98","doi-asserted-by":"crossref","unstructured":"Cao K, Capell BC, Erdos MR et al (2007) A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells. Proc Natl Acad Sci USA 104:4949\u20134954","DOI":"10.1073\/pnas.0611640104"},{"key":"4_CR99","doi-asserted-by":"crossref","unstructured":"Cobb AM, Murray TV, Warren DT et al (2016) Disruption of PCNA-lamins A\/C interactions by prelamin A induces DNA replication fork stalling. Nucleus 7:498\u2013511","DOI":"10.1080\/19491034.2016.1239685"},{"key":"4_CR100","doi-asserted-by":"crossref","unstructured":"Liu B, Wang J, Chan KM et al (2005) Genomic instability in laminopathy-based premature aging. Nat Med 11:780\u2013785","DOI":"10.1038\/nm1266"},{"key":"4_CR101","doi-asserted-by":"crossref","unstructured":"Chojnowski A, Ong PF, Wong ESM et al (2015) Progerin reduces LAP2\u03b1-telomere association in Hutchinson-Gilford progeria. elife 4:e07759","DOI":"10.7554\/eLife.07759"},{"key":"4_CR102","doi-asserted-by":"crossref","unstructured":"Frankel D, Delecourt V, Novoa-Del-Toro E-M et al (2022) miR-376a-3p and miR-376b-3p overexpression in Hutchinson-Gilford progeria fibroblasts inhibits cell proliferation and induces premature senescence. iScience 25:103757","DOI":"10.1016\/j.isci.2022.103757"},{"key":"4_CR103","doi-asserted-by":"crossref","unstructured":"Dahl KN, Scaffidi P, Islam MF et al (2006) Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 103:10271\u201310276","DOI":"10.1073\/pnas.0601058103"},{"key":"4_CR104","doi-asserted-by":"crossref","unstructured":"Lammerding J, Schulze PC, Takahashi T et al (2004) Lamin A\/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113:370\u2013378","DOI":"10.1172\/JCI200419670"},{"key":"4_CR105","doi-asserted-by":"crossref","unstructured":"Richards SA, Muter J, Ritchie P et al (2011) The accumulation of un-repairable DNA damage in laminopathy progeria fibroblasts is caused by ROS generation and is prevented by treatment with N-acetyl cysteine. Hum Mol Genet 20:3997\u20134004","DOI":"10.1093\/hmg\/ddr327"},{"key":"4_CR106","doi-asserted-by":"crossref","unstructured":"Viteri G, Chung YW, Stadtman ER (2010) Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients. Mech Ageing Dev 131:2\u20138","DOI":"10.1016\/j.mad.2009.11.006"},{"key":"4_CR107","doi-asserted-by":"crossref","unstructured":"Jung H-J, Coffinier C, Choe Y et al (2012) Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA. Proc Natl Acad Sci USA 109:E423\u2013E431","DOI":"10.1073\/pnas.1111780109"},{"key":"4_CR108","doi-asserted-by":"crossref","unstructured":"Nissan X, Blondel S, Navarro C et al (2012) Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA. Cell Rep 2:1\u20139","DOI":"10.1016\/j.celrep.2012.05.015"},{"key":"4_CR109","doi-asserted-by":"crossref","unstructured":"Hu Q, Zhang N, Sui T et al (2023) Anti-hsa-miR-59 alleviates premature senescence associated with Hutchinson-Gilford progeria syndrome in mice. EMBO J 42:e110937","DOI":"10.15252\/embj.2022110937"},{"key":"4_CR110","doi-asserted-by":"crossref","unstructured":"Manakanatas C, Ghadge SK, Agic A et al (2022) Endothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria. Aging (Albany NY) 14:195\u2013224","DOI":"10.18632\/aging.203820"},{"key":"4_CR111","doi-asserted-by":"crossref","unstructured":"Coll-Bonfill N, Mahajan U, Shashkova EV et al (2023) Progerin induces a phenotypic switch in vascular smooth muscle cells and triggers replication stress and an aging-associated secretory signature. Geroscience 45:965\u2013982","DOI":"10.1007\/s11357-022-00694-1"},{"key":"4_CR112","doi-asserted-by":"crossref","unstructured":"Olive M, Harten I, Mitchell R et al (2010) Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging. Arterioscler Thromb Vasc Biol 30:2301\u20132309","DOI":"10.1161\/ATVBAHA.110.209460"},{"key":"4_CR113","doi-asserted-by":"crossref","unstructured":"Stehbens WE, Delahunt B, Shozawa T, Gilbert-Barness E (2001) Smooth muscle cell depletion and collagen types in progeric arteries. Cardiovasc Pathol 10:133\u2013136","DOI":"10.1016\/S1054-8807(01)00069-2"},{"key":"4_CR114","doi-asserted-by":"crossref","unstructured":"Varga R, Eriksson M, Erdos MR et al (2006) Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 103:3250\u20133255","DOI":"10.1073\/pnas.0600012103"},{"key":"4_CR115","doi-asserted-by":"crossref","unstructured":"Bidault G, Garcia M, Capeau J et al (2020) Progerin expression induces inflammation, oxidative stress and senescence in human coronary endothelial cells. Cells 9:1201","DOI":"10.3390\/cells9051201"},{"key":"4_CR116","doi-asserted-by":"crossref","unstructured":"Xu Q, Mojiri A, Boulahouache L et al (2022) Vascular senescence in progeria: role of endothelial dysfunction. Eur Heart J Open 2:oeac047","DOI":"10.1093\/ehjopen\/oeac047"},{"key":"4_CR117","doi-asserted-by":"crossref","unstructured":"Hamczyk MR, Andr\u00e9s V (2019) Vascular smooth muscle cell loss underpins the accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome. Nucleus 10:28\u201334","DOI":"10.1080\/19491034.2019.1589359"},{"key":"4_CR118","doi-asserted-by":"crossref","unstructured":"Gordon LB, Kleinman ME, Miller DT et al (2012) Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 109:16666\u201316671","DOI":"10.1073\/pnas.1202529109"},{"key":"4_CR119","doi-asserted-by":"crossref","unstructured":"Cao K, Graziotto JJ, Blair CD et al (2011) Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med 3:89ra58","DOI":"10.1126\/scitranslmed.3002346"},{"key":"4_CR120","doi-asserted-by":"crossref","unstructured":"Cenni V, Capanni C, Columbaro M et al (2011) Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria. Eur J Histochem 55:e36","DOI":"10.4081\/ejh.2011.e36"},{"key":"4_CR121","doi-asserted-by":"crossref","unstructured":"Gabriel D, Gordon LB, Djabali K (2016) Temsirolimus partially rescues the Hutchinson-Gilford progeria cellular phenotype. PLoS One 11:e0168988","DOI":"10.1371\/journal.pone.0168988"},{"key":"4_CR122","doi-asserted-by":"crossref","unstructured":"Gabriel D, Roedl D, Gordon LB, Djabali K (2015) Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts. Aging Cell 14:78\u201391","DOI":"10.1111\/acel.12300"},{"key":"4_CR123","doi-asserted-by":"crossref","unstructured":"Harhouri K, Navarro C, Depetris D et al (2017) MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation. EMBO Mol Med 9:1294","DOI":"10.15252\/emmm.201607315"},{"key":"4_CR124","doi-asserted-by":"crossref","unstructured":"Kang HT, Park JT, Choi K et al (2017) Chemical screening identifies ROCK as a target for recovering mitochondrial function in Hutchinson-Gilford progeria syndrome. Aging Cell 16:541\u2013550","DOI":"10.1111\/acel.12584"},{"key":"4_CR125","doi-asserted-by":"crossref","unstructured":"Kreienkamp R, Croke M, Neumann MA et al (2016) Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes. Oncotarget 7:30018\u201330031","DOI":"10.18632\/oncotarget.9065"},{"key":"4_CR126","doi-asserted-by":"crossref","unstructured":"Liu B, Ghosh S, Yang X et al (2012) Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria. Cell Metab 16:738\u2013750","DOI":"10.1016\/j.cmet.2012.11.007"},{"key":"4_CR127","doi-asserted-by":"crossref","unstructured":"Osorio FG, Navarro CL, Cadi\u00f1anos J et al (2011) Splicing-directed therapy in a new mouse model of human accelerated aging. Sci Transl Med 3:106ra107","DOI":"10.1126\/scitranslmed.3002847"},{"key":"4_CR128","doi-asserted-by":"crossref","unstructured":"Beyret E, Liao H-K, Yamamoto M et al (2019) Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. Nat Med 25:419\u2013422","DOI":"10.1038\/s41591-019-0343-4"},{"key":"4_CR129","doi-asserted-by":"crossref","unstructured":"Santiago-Fern\u00e1ndez O, Osorio FG, Quesada V et al (2019) Development of a CRISPR\/Cas9-based therapy for Hutchinson-Gilford progeria syndrome. Nat Med 25:423\u2013426","DOI":"10.1038\/s41591-018-0338-6"},{"key":"4_CR130","doi-asserted-by":"crossref","unstructured":"Koblan LW, Erdos MR, Wilson C et al (2021) In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice. Nature 589:608\u2013614","DOI":"10.1038\/s41586-020-03086-7"},{"key":"4_CR131","doi-asserted-by":"crossref","unstructured":"Whisenant D, Lim K, Rev\u00eachon G et al (2022) Transient expression of an adenine base editor corrects the Hutchinson-Gilford progeria syndrome mutation and improves the skin phenotype in mice. Nat Commun 13:3068","DOI":"10.1038\/s41467-022-30800-y"},{"key":"4_CR132","doi-asserted-by":"crossref","unstructured":"Barth\u00e9l\u00e9my F, Navarro C, Fayek R et al (2015) Truncated prelamin A expression in HGPS-like patients: a transcriptional study. Eur J Hum Genet 23:1051\u20131061","DOI":"10.1038\/ejhg.2014.239"},{"key":"4_CR133","doi-asserted-by":"crossref","unstructured":"Moulson CL, Fong LG, Gardner JM et al (2007) Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes. Hum Mutat 28:882\u2013889","DOI":"10.1002\/humu.20536"},{"key":"4_CR134","doi-asserted-by":"crossref","unstructured":"Bar DZ, Arlt MF, Brazier JF et al (2017) A novel somatic mutation achieves partial rescue in a child with Hutchinson-Gilford progeria syndrome. J Med Genet 54:212\u2013216","DOI":"10.1136\/jmedgenet-2016-104295"},{"key":"4_CR135","unstructured":"Gordon LB, Brown WT, Collins FS (2023) Hutchinson-Gilford progeria syndrome. In: GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"key":"4_CR136","doi-asserted-by":"crossref","unstructured":"Lombardi F, Gullotta F, Columbaro M et al (2007) Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype. J Clin Endocrinol Metab 92:4467\u20134471","DOI":"10.1210\/jc.2007-0116"},{"key":"4_CR137","doi-asserted-by":"crossref","unstructured":"Garg A, Subramanyam L, Agarwal AK et al (2009) Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J Clin Endocrinol Metabol 94:4971\u20134983","DOI":"10.1210\/jc.2009-0472"},{"key":"4_CR138","doi-asserted-by":"crossref","unstructured":"Plasilova M, Chattopadhyay C, Pal P et al (2004) Homozygous missense mutation in the lamin A\/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome. J Med Genet 41:609\u2013614","DOI":"10.1136\/jmg.2004.019661"},{"key":"4_CR139","doi-asserted-by":"crossref","unstructured":"Verstraeten VLRM, Broers JLV, van Steensel MAM et al (2006) Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation. Hum Mol Genet 15:2509\u20132522","DOI":"10.1093\/hmg\/ddl172"},{"key":"4_CR140","unstructured":"Danks DM, Mayne V, Wettenhall NB, Hall RK (1974) Craniomandibular dermatodysostosis. Birth Defects Orig Artic Ser 10:99\u2013105"},{"key":"4_CR141","unstructured":"Young LW, Radebaugh JF, Rubin P et al (1971) New syndrome manifested by mandibular hypoplasia, acroosteolysis, stiff joints and cutaneous atrophy (mandibuloacral dysplasia) in two unrelated boys. Birth Defects Orig Artic Ser 7:291\u2013297"},{"key":"4_CR142","doi-asserted-by":"crossref","unstructured":"J\u00e9ru I, Nabil A, El-Makkawy G et al (2021) Two decades after mandibuloacral dysplasia discovery: additional cases and comprehensive view of disease characteristics. Genes (Basel) 12:1508","DOI":"10.3390\/genes12101508"},{"key":"4_CR143","doi-asserted-by":"crossref","unstructured":"Cenni V, D\u2019Apice MR, Garagnani P et al (2018) Mandibuloacral dysplasia: a premature ageing disease with aspects of physiological ageing. Ageing Res Rev 42:1\u201313","DOI":"10.1016\/j.arr.2017.12.001"},{"key":"4_CR144","doi-asserted-by":"crossref","unstructured":"Novelli G, Muchir A, Sangiuolo F et al (2002) Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C. Am J Hum Genet 71:426\u2013431","DOI":"10.1086\/341908"},{"key":"4_CR145","doi-asserted-by":"crossref","unstructured":"Simha V, Garg A (2002) Body fat distribution and metabolic derangements in patients with familial partial lipodystrophy associated with mandibuloacral dysplasia. J Clin Endocrinol Metab 87:776\u2013785","DOI":"10.1210\/jc.87.2.776"},{"key":"4_CR146","doi-asserted-by":"crossref","unstructured":"Agarwal AK, Fryns J-P, Auchus RJ, Garg A (2003) Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 12:1995\u20132001","DOI":"10.1093\/hmg\/ddg213"},{"key":"4_CR147","doi-asserted-by":"crossref","unstructured":"Kosho T, Takahashi J, Momose T et al (2007) Mandibuloacral dysplasia and a novel LMNA mutation in a woman with severe progressive skeletal changes. Am J Med Genet A 143A:2598\u20132603","DOI":"10.1002\/ajmg.a.31983"},{"key":"4_CR148","doi-asserted-by":"crossref","unstructured":"Ozer L, Unsal E, Aktuna S et al (2016) Mandibuloacral dysplasia and LMNA A529V mutation in Turkish patients with severe skeletal changes and absent breast development. Clin Dysmorphol 25:91\u201397","DOI":"10.1097\/MCD.0000000000000132"},{"key":"4_CR149","doi-asserted-by":"crossref","unstructured":"Zirn B, Kress W, Grimm T et al (2008) Association of homozygous LMNA mutation R471C with new phenotype: mandibuloacral dysplasia, progeria, and rigid spine muscular dystrophy. Am J Med Genet A 146A:1049\u20131054","DOI":"10.1002\/ajmg.a.32259"},{"key":"4_CR150","doi-asserted-by":"crossref","unstructured":"Agarwal AK, Kazachkova I, Ten S, Garg A (2008) Severe mandibuloacral dysplasia-associated lipodystrophy and progeria in a young girl with a novel homozygous Arg527Cys LMNA mutation. J Clin Endocrinol Metab 93:4617\u20134623","DOI":"10.1210\/jc.2008-0123"},{"key":"4_CR151","doi-asserted-by":"crossref","unstructured":"Luo D-Q, Wang X-Z, Meng Y et al (2014) Mandibuloacral dysplasia type A-associated progeria caused by homozygous LMNA mutation in a family from Southern China. BMC Pediatr 14:256","DOI":"10.1186\/1471-2431-14-256"},{"key":"4_CR152","doi-asserted-by":"crossref","unstructured":"Yassaee VR, Khojaste A, Hashemi-Gorji F et al (2016) A novel homozygous LMNA mutation (p.Met540Ile) causes mandibuloacral dysplasia type A. Gene 577:8\u201313","DOI":"10.1016\/j.gene.2015.08.071"},{"key":"4_CR153","doi-asserted-by":"crossref","unstructured":"Agarwal AK, Zhou XJ, Hall RK et al (2006) Focal segmental glomerulosclerosis in patients with mandibuloacral dysplasia owing to ZMPSTE24 deficiency. J Investig Med 54:208\u2013213","DOI":"10.2310\/6650.2006.05068"},{"key":"4_CR154","doi-asserted-by":"crossref","unstructured":"Shackleton S, Smallwood DT, Clayton P et al (2005) Compound heterozygous ZMPSTE24 mutations reduce prelamin A processing and result in a severe progeroid phenotype. J Med Genet 42:e36","DOI":"10.1136\/jmg.2004.029751"},{"key":"4_CR155","doi-asserted-by":"crossref","unstructured":"Miyoshi Y, Akagi M, Agarwal AK et al (2008) Severe mandibuloacral dysplasia caused by novel compound heterozygous ZMPSTE24 mutations in two Japanese siblings. Clin Genet 73:535\u2013544","DOI":"10.1111\/j.1399-0004.2008.00992.x"},{"key":"4_CR156","doi-asserted-by":"crossref","unstructured":"Cunningham VJ, D\u2019Apice MR, Licata N et al (2010) Skeletal phenotype of mandibuloacral dysplasia associated with mutations in ZMPSTE24. Bone 47:591\u2013597","DOI":"10.1016\/j.bone.2010.06.004"},{"key":"4_CR157","doi-asserted-by":"crossref","unstructured":"Haye D, Dridi H, Levy J et al (2016) Failure of ossification of the occipital bone in mandibuloacral dysplasia type B. Am J Med Genet A 170:2750\u20132755","DOI":"10.1002\/ajmg.a.37825"},{"key":"4_CR158","doi-asserted-by":"crossref","unstructured":"Ahmad Z, Zackai E, Medne L, Garg A (2010) Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24. Am J Med Genet A 152A:2703\u20132710","DOI":"10.1002\/ajmg.a.33664"},{"key":"4_CR159","doi-asserted-by":"crossref","unstructured":"Alarc\u00f3n PI, Mujica I, Sanz P et al (2019) Mandibuloacral dysplasia with type B lipodystrophy in a patient from Chile. Am J Med Genet A 179:893\u2013895","DOI":"10.1002\/ajmg.a.61139"},{"key":"4_CR160","doi-asserted-by":"crossref","unstructured":"Hitzert MM, van der Crabben SN, Baldewsingh G et al (2019) Mandibuloacral dysplasia type B (MADB): a cohort of eight patients from Suriname with a homozygous founder mutation in ZMPSTE24 (FACE1), clinical diagnostic criteria and management guidelines. Orphanet J Rare Dis 14:294","DOI":"10.1186\/s13023-019-1269-0"},{"key":"4_CR161","doi-asserted-by":"crossref","unstructured":"Harhouri K, Navarro C, Baquerre C et al (2016) Antisense-based Progerin downregulation in HGPS-like patients\u2019 cells. Cells 5","DOI":"10.3390\/cells5030031"},{"key":"4_CR162","doi-asserted-by":"crossref","unstructured":"Ben Yaou R, Navarro C, Quijano-Roy S et al (2011) Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation. Eur J Hum Genet 19:647\u2013654","DOI":"10.1038\/ejhg.2010.256"},{"key":"4_CR163","doi-asserted-by":"crossref","unstructured":"Camozzi D, D\u2019Apice MR, Schena E et al (2012) Altered chromatin organization and SUN2 localization in mandibuloacral dysplasia are rescued by drug treatment. Histochem Cell Biol 138:643","DOI":"10.1007\/s00418-012-0977-5"},{"key":"4_CR164","doi-asserted-by":"crossref","unstructured":"Cenni V, Capanni C, Mattioli E et al (2014) Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics. Aging (Albany NY) 6:755\u2013770","DOI":"10.18632\/aging.100680"},{"key":"4_CR165","doi-asserted-by":"crossref","unstructured":"Filesi I, Gullotta F, Lattanzi G et al (2005) Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy. Physiol Genomics 23:150\u2013158","DOI":"10.1152\/physiolgenomics.00060.2005"},{"key":"4_CR166","doi-asserted-by":"crossref","unstructured":"di Masi A, D\u2019Apice MR, Ricordy R et al (2008) The R527H mutation in LMNA gene causes an increased sensitivity to ionizing radiation. Cell Cycle 7:2030\u20132037","DOI":"10.4161\/cc.7.13.6149"},{"key":"4_CR167","doi-asserted-by":"crossref","unstructured":"Avnet S, Pallotta R, Perut F et al (2011) Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts. Biochim Biophys Acta 1812:711\u2013718","DOI":"10.1016\/j.bbadis.2011.03.006"},{"key":"4_CR168","doi-asserted-by":"crossref","unstructured":"He L, Liao J, Liu Z et al (2023) Multi-omic analysis of mandibuloacral dysplasia type A patient iPSC-derived MSC senescence reveals miR-311 as a novel biomarker for MSC senescence. Hum Mol Genet 32:2872\u20132886","DOI":"10.1093\/hmg\/ddad111"},{"key":"4_CR169","doi-asserted-by":"crossref","unstructured":"Hartinger R, Lederer E-M, Schena E et al (2023) Impact of combined Baricitinib and FTI treatment on adipogenesis in Hutchinson-Gilford progeria syndrome and other lipodystrophic laminopathies. Cells 12:1350","DOI":"10.3390\/cells12101350"},{"key":"4_CR170","doi-asserted-by":"crossref","unstructured":"Elouej S, Beleza-Meireles A, Caswell R et al (2017) Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL). Metabolism 71:213\u2013225","DOI":"10.1016\/j.metabol.2017.03.011"},{"key":"4_CR171","doi-asserted-by":"crossref","unstructured":"Weedon MN, Ellard S, Prindle MJ et al (2013) An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat Genet 45:947\u2013950","DOI":"10.1038\/ng.2670"},{"key":"4_CR172","doi-asserted-by":"crossref","unstructured":"Murdocca M, Spitalieri P, De Masi C et al (2021) Functional analysis of POLD1 p.ser605del variant: the aging phenotype of MDPL syndrome is associated with an impaired DNA repair capacity. Aging (Albany NY) 13:4926\u20134945","DOI":"10.18632\/aging.202680"},{"key":"4_CR173","doi-asserted-by":"crossref","unstructured":"Murdocca M, Spitalieri P, Cappello A et al (2022) Mitochondrial dysfunction in mandibular hypoplasia, deafness and progeroid features with concomitant lipodystrophy (MDPL) patients. Aging (Albany NY) 14:1651\u20131664","DOI":"10.18632\/aging.203910"},{"key":"4_CR174","doi-asserted-by":"crossref","unstructured":"Elouej S, Harhouri K, Le Mao M et al (2020) Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology. Nat Commun 11:4589","DOI":"10.1038\/s41467-020-18146-9"},{"key":"4_CR175","doi-asserted-by":"crossref","unstructured":"Yeter Do\u011fan B, G\u00fcnay N, Ada Y, Do\u011fan ME (2023) A novel MTX2 gene splice site variant resulting in exon skipping, causing the recently described mandibuloacral dysplasia progeroid syndrome. Am J Med Genet A 191:173\u2013182","DOI":"10.1002\/ajmg.a.63010"},{"key":"4_CR176","doi-asserted-by":"crossref","unstructured":"Toriello HV (1986) Restrictive dermopathy and report of another case. Am J Med Genet 24:625\u2013629","DOI":"10.1002\/ajmg.1320240407"},{"key":"4_CR177","doi-asserted-by":"crossref","unstructured":"Witt DR, Hayden MR, Holbrook KA et al (1986) Restrictive dermopathy: a newly recognized autosomal recessive skin dysplasia. Am J Med Genet 24:631\u2013648","DOI":"10.1002\/ajmg.1320240408"},{"key":"4_CR178","doi-asserted-by":"crossref","unstructured":"Scott JB, Yanes AF, Vivar KL et al (2021) Restrictive dermopathy: three new patients with ZMPSTE24 mutations and a review of the literature. Pediatr Dermatol 38:1535\u20131540","DOI":"10.1111\/pde.14822"},{"key":"4_CR179","doi-asserted-by":"crossref","unstructured":"Hall JG, Kiefer J (2016) Arthrogryposis as a syndrome: gene ontology analysis. Mol Syndromol 7:101\u2013109","DOI":"10.1159\/000446617"},{"key":"4_CR180","doi-asserted-by":"crossref","unstructured":"Niles KM, Blaser S, Shannon P, Chitayat D (2019) Fetal arthrogryposis multiplex congenita\/fetal akinesia deformation sequence (FADS)-Aetiology, diagnosis, and management. Prenat Diagn 39:720\u2013731","DOI":"10.1002\/pd.5505"},{"key":"4_CR181","doi-asserted-by":"crossref","unstructured":"Mau U, Kendziorra H, Kaiser P, Enders H (1997) Restrictive dermopathy: report and review. Am J Med Genet 71:179\u2013185","DOI":"10.1002\/(SICI)1096-8628(19970808)71:2<179::AID-AJMG11>3.0.CO;2-B"},{"key":"4_CR182","doi-asserted-by":"crossref","unstructured":"Morais P, Magina S, Ribeiro M d C et al (2009) Restrictive dermopathy\u2013a lethal congenital laminopathy. Case report and review of the literature. Eur J Pediatr 168:1007\u20131012","DOI":"10.1007\/s00431-008-0868-x"},{"key":"4_CR183","doi-asserted-by":"crossref","unstructured":"Pradeep I, Gowrishankar K, Shanmugasundaram L (2022) Lethal restrictive dermopathy with ZMPSTE24 mutation. Pediatr Dev Pathol 25:327\u2013329","DOI":"10.1177\/10935266211065316"},{"key":"4_CR184","doi-asserted-by":"crossref","unstructured":"Nijsten TEC, De Moor A, Colpaert CG et al (2002) Restrictive dermopathy: a case report and a critical review of all hypotheses of its origin. Pediatr Dermatol 19:67\u201372","DOI":"10.1046\/j.1525-1470.2002.00029.x"},{"key":"4_CR185","doi-asserted-by":"crossref","unstructured":"Navarro CL, De Sandre-Giovannoli A, Bernard R et al (2004) Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 13:2493\u20132503","DOI":"10.1093\/hmg\/ddh265"},{"key":"4_CR186","doi-asserted-by":"crossref","unstructured":"Moulson CL, Go G, Gardner JM et al (2005) Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. J Invest Dermatol 125:913\u2013919","DOI":"10.1111\/j.0022-202X.2005.23846.x"},{"key":"4_CR187","doi-asserted-by":"crossref","unstructured":"Navarro CL, Cadi\u00f1anos J, De Sandre-Giovannoli A et al (2005) Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum Mol Genet 14:1503\u20131513","DOI":"10.1093\/hmg\/ddi159"},{"key":"4_CR188","doi-asserted-by":"crossref","unstructured":"Smigiel R, Jakubiak A, Esteves-Vieira V et al (2010) Novel frameshifting mutations of the ZMPSTE24 gene in two siblings affected with restrictive dermopathy and review of the mutations described in the literature. Am J Med Genet A 152A:447\u2013452","DOI":"10.1002\/ajmg.a.33221"},{"key":"4_CR189","doi-asserted-by":"crossref","unstructured":"Barrowman J, Wiley PA, Hudon-Miller SE et al (2012) Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity. Hum Mol Genet 21:4084\u20134093","DOI":"10.1093\/hmg\/dds233"},{"key":"4_CR190","doi-asserted-by":"crossref","unstructured":"Sevenants L, Wouters C, De Sandre-Giovannoli A et al (2005) Tight skin and limited joint movements as early presentation of Hutchinson-Gilford progeria in a 7-week-old infant. Eur J Pediatr 164:283\u2013286","DOI":"10.1007\/s00431-005-1635-x"},{"key":"4_CR191","doi-asserted-by":"crossref","unstructured":"Starke S, Meinke P, Camozzi D et al (2013) Progeroid laminopathy with restrictive dermopathy-like features caused by an isodisomic LMNA mutation p.R435C. Aging (Albany NY) 5:445\u2013459","DOI":"10.18632\/aging.100566"},{"key":"4_CR192","doi-asserted-by":"crossref","unstructured":"Youn GJ, Uzunyan M, Vachon L et al (2010) Autosomal recessive LMNA mutation causing restrictive dermopathy. Clin Genet 78:199\u2013200","DOI":"10.1111\/j.1399-0004.2010.01385.x"},{"key":"4_CR193","doi-asserted-by":"crossref","unstructured":"Evangelisti C, Rusciano I, Mongiorgi S et al (2022) The wide and growing range of lamin B-related diseases: from laminopathies to cancer. Cell Mol Life Sci 79:126","DOI":"10.1007\/s00018-021-04084-2"},{"key":"4_CR194","doi-asserted-by":"crossref","unstructured":"Odell J, Lammerding J (2023) Lamins as structural nuclear elements through evolution. Curr Opin Cell Biol 85:102267","DOI":"10.1016\/j.ceb.2023.102267"},{"key":"4_CR195","doi-asserted-by":"crossref","unstructured":"Neri I, Ramazzotti G, Mongiorgi S et al (2023) Understanding the ultra-rare disease autosomal dominant leukodystrophy: an updated review on morpho-functional alterations found in experimental models. Mol Neurobiol 60:6362\u20136372","DOI":"10.1007\/s12035-023-03461-1"},{"key":"4_CR196","doi-asserted-by":"crossref","unstructured":"Kim Y (2023) The impact of altered lamin B1 levels on nuclear lamina structure and function in aging and human diseases. Curr Opin Cell Biol 85:102257","DOI":"10.1016\/j.ceb.2023.102257"},{"key":"4_CR197","unstructured":"Raininko R, Gosky M, Padiath QS (1993) LMNB1-related autosomal dominant leukodystrophy. In: Adam MP, Feldman J, Mirzaa GM et al (eds) GeneReviews\u00ae. University of Washington, Seattle (WA)"},{"key":"4_CR198","doi-asserted-by":"crossref","unstructured":"Giorgio E, Robyr D, Spielmann M et al (2015) A large genomic deletion leads to enhancer adoption by the lamin B1 gene: a second path to autosomal dominant adult-onset demyelinating leukodystrophy (ADLD). Hum Mol Genet 24:3143\u20133154","DOI":"10.1093\/hmg\/ddv065"},{"key":"4_CR199","doi-asserted-by":"crossref","unstructured":"Padiath QS, Saigoh K, Schiffmann R et al (2006) Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet 38:1114\u20131123","DOI":"10.1038\/ng1872"},{"key":"4_CR200","doi-asserted-by":"crossref","unstructured":"Padiath QS (2019) Autosomal dominant leukodystrophy: a disease of the nuclear lamina. Front Cell Dev Biol 7:41","DOI":"10.3389\/fcell.2019.00041"},{"key":"4_CR201","doi-asserted-by":"crossref","unstructured":"Heng MY, Lin S-T, Verret L et al (2013) Lamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse model. J Clin Invest 123:2719\u20132729","DOI":"10.1172\/JCI66737"},{"key":"4_CR202","doi-asserted-by":"crossref","unstructured":"Rolyan H, Tyurina YY, Hernandez M et al (2015) Defects of lipid synthesis are linked to the age-dependent demyelination caused by Lamin B1 overexpression. J Neurosci 35:12002\u201312017","DOI":"10.1523\/JNEUROSCI.1668-15.2015"},{"key":"4_CR203","doi-asserted-by":"crossref","unstructured":"Ferrera D, Canale C, Marotta R et al (2014) Lamin B1 overexpression increases nuclear rigidity in autosomal dominant leukodystrophy fibroblasts. FASEB J 28:3906\u20133918","DOI":"10.1096\/fj.13-247635"},{"key":"4_CR204","doi-asserted-by":"crossref","unstructured":"Cristofoli F, Moss T, Moore HW et al (2020) De Novo variants in LMNB1 cause pronounced syndromic microcephaly and disruption of nuclear envelope integrity. Am J Hum Genet 107:753\u2013762","DOI":"10.1016\/j.ajhg.2020.08.015"},{"key":"4_CR205","doi-asserted-by":"crossref","unstructured":"Parry DA, Martin C-A, Greene P et al (2021) Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly and define a novel laminopathy. Genet Med 23:408\u2013414","DOI":"10.1038\/s41436-020-00980-3"},{"key":"4_CR206","doi-asserted-by":"crossref","unstructured":"Coffinier C, Jung H-J, Nobumori C et al (2011) Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons. Mol Biol Cell 22:4683\u20134693","DOI":"10.1091\/mbc.e11-06-0504"},{"key":"4_CR207","doi-asserted-by":"crossref","unstructured":"Dittmer TA, Misteli T (2011) The lamin protein family. Genome Biol 12:222","DOI":"10.1186\/gb-2011-12-5-222"},{"key":"4_CR208","doi-asserted-by":"crossref","unstructured":"Damiano JA, Afawi Z, Bahlo M et al (2015) Mutation of the nuclear lamin gene LMNB2 in progressive myoclonus epilepsy with early ataxia. Hum Mol Genet 24:4483\u20134490","DOI":"10.1093\/hmg\/ddv171"},{"key":"4_CR209","doi-asserted-by":"crossref","unstructured":"Farajzadeh Valilou S, Karimzad Hagh J, Salimi Asl M et al (2021) A novel biallelic LMNB2 variant in a patient with progressive myoclonus epilepsy and ataxia: a case of laminopathy. Clin Case Rep 9:e04520","DOI":"10.1002\/ccr3.4520"},{"key":"4_CR210","doi-asserted-by":"crossref","unstructured":"Soleimanipour F, Razmara E, Rahbarizadeh F et al (2022) A novel missense variant in the LMNB2 gene causes progressive myoclonus epilepsy. Acta Neurol Belg 122:659\u2013667","DOI":"10.1007\/s13760-021-01650-0"},{"key":"4_CR211","doi-asserted-by":"crossref","unstructured":"Akinci B, Onay H, Demir T et al (2017) Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy. Metab Clin Exp 72:109\u2013119","DOI":"10.1016\/j.metabol.2017.04.010"},{"key":"4_CR212","doi-asserted-by":"crossref","unstructured":"Hegele RA, Cao H, Liu DM et al (2006) Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am J Hum Genet 79:383\u2013389","DOI":"10.1086\/505885"},{"key":"4_CR213","doi-asserted-by":"crossref","unstructured":"Gao J, Li Y, Fu X, Luo X (2012) A Chinese patient with acquired partial lipodystrophy caused by a novel mutation with LMNB2 gene. J Pediatr Endocrinol Metab 25:375\u2013377","DOI":"10.1515\/jpem-2012-0007"},{"key":"4_CR214","doi-asserted-by":"crossref","unstructured":"Guelen L, Pagie L, Brasset E et al (2008) Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453:948\u2013951","DOI":"10.1038\/nature06947"},{"key":"4_CR215","doi-asserted-by":"crossref","unstructured":"Meuleman W, Peric-Hupkes D, Kind J et al (2013) Constitutive nuclear lamina-genome interactions are highly conserved and associated with A\/T-rich sequence. Genome Res 23:270\u2013280","DOI":"10.1101\/gr.141028.112"},{"key":"4_CR216","doi-asserted-by":"crossref","unstructured":"van Steensel B, Belmont AS (2017) Lamina-associated domains: links with chromosome architecture, heterochromatin, and gene repression. Cell 169:780\u2013791","DOI":"10.1016\/j.cell.2017.04.022"},{"key":"4_CR217","doi-asserted-by":"crossref","unstructured":"Camozzi D, Capanni C, Cenni V et al (2014) Diverse lamin-dependent mechanisms interact to control chromatin dynamics. Nucleus 5:427\u2013440","DOI":"10.4161\/nucl.36289"},{"key":"4_CR218","doi-asserted-by":"crossref","unstructured":"Alagna NS, Thomas TI, Wilson KL, Reddy KL (2023) Choreography of lamina-associated domains: structure meets dynamics. FEBS Lett 597:2806\u20132822","DOI":"10.1002\/1873-3468.14771"},{"key":"4_CR219","doi-asserted-by":"crossref","unstructured":"Cho S, Irianto J, Discher DE (2017) Mechanosensing by the nucleus: from pathways to scaling relationships. J Cell Biol 216:305\u2013315","DOI":"10.1083\/jcb.201610042"},{"key":"4_CR220","doi-asserted-by":"crossref","unstructured":"Davidson PM, Lammerding J (2014) Broken nuclei\u2014lamins, nuclear mechanics, and disease. Trends Cell Biol 24:247\u2013256","DOI":"10.1016\/j.tcb.2013.11.004"},{"key":"4_CR221","doi-asserted-by":"crossref","unstructured":"Kalukula Y, Stephens AD, Lammerding J, Gabriele S (2022) Mechanics and functional consequences of nuclear deformations. Nat Rev Mol Cell Biol 23:583\u2013602","DOI":"10.1038\/s41580-022-00480-z"},{"key":"4_CR222","doi-asserted-by":"crossref","unstructured":"Tajik A, Zhang Y, Wei F et al (2016) Transcription upregulation via force-induced direct stretching of chromatin. Nat Mater 15:1287\u20131296","DOI":"10.1038\/nmat4729"},{"key":"4_CR223","doi-asserted-by":"crossref","unstructured":"Shah PP, Santini GT, Shen KM, Jain R (2023) InterLINCing chromatin organization and mechanobiology in laminopathies. Curr Cardiol Rep 25:307\u2013314","DOI":"10.1007\/s11886-023-01853-2"},{"key":"4_CR224","doi-asserted-by":"crossref","unstructured":"Shah PP, Lv W, Rhoades JH et al (2021) Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes. Cell Stem Cell 28:938\u2013954.e9","DOI":"10.1016\/j.stem.2020.12.016"},{"key":"4_CR225","doi-asserted-by":"crossref","unstructured":"Buxboim A, Kronenberg-Tenga R, Salajkova S et al (2023) Scaffold, mechanics and functions of nuclear lamins. FEBS Lett 597:2791\u20132805","DOI":"10.1002\/1873-3468.14750"},{"key":"4_CR226","doi-asserted-by":"crossref","unstructured":"Handoko L, Xu H, Li G et al (2011) CTCF-mediated functional chromatin interactome in pluripotent cells. Nat Genet 43:630\u2013638","DOI":"10.1038\/ng.857"},{"key":"4_CR227","doi-asserted-by":"crossref","unstructured":"Pickersgill H, Kalverda B, de Wit E et al (2006) Characterization of the Drosophila melanogaster genome at the nuclear lamina. Nat Genet 38:1005\u20131014","DOI":"10.1038\/ng1852"},{"key":"4_CR228","doi-asserted-by":"crossref","unstructured":"Cheedipudi SM, Matkovich SJ, Coarfa C et al (2019) Genomic reorganization of Lamin-associated domains in cardiac myocytes is associated with differential gene expression and DNA methylation in human dilated cardiomyopathy. Circ Res 124:1198\u20131213","DOI":"10.1161\/CIRCRESAHA.118.314177"},{"key":"4_CR229","doi-asserted-by":"crossref","unstructured":"Harr JC, Schmid CD, Mu\u00f1oz-Jim\u00e9nez C et al (2020) Loss of an H3K9me anchor rescues laminopathy-linked changes in nuclear organization and muscle function in an Emery-Dreifuss muscular dystrophy model. Genes Dev 34:560\u2013579","DOI":"10.1101\/gad.332213.119"},{"key":"4_CR230","doi-asserted-by":"crossref","unstructured":"Perovanovic J, Dell\u2019Orso S, Gnochi VF et al (2016) Laminopathies disrupt epigenomic developmental programs and cell fate. Sci Transl Med 8:335ra58","DOI":"10.1126\/scitranslmed.aad4991"},{"key":"4_CR231","doi-asserted-by":"crossref","unstructured":"Gonzalo S, Kreienkamp R (2015) DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome. Curr Opin Cell Biol 34:75\u201383","DOI":"10.1016\/j.ceb.2015.05.007"},{"key":"4_CR232","doi-asserted-by":"crossref","unstructured":"Nava MM, Miroshnikova YA, Biggs LC et al (2020) Heterochromatin-driven nuclear softening protects the genome against mechanical stress-induced damage. Cell 181:800\u2013817.e22","DOI":"10.1016\/j.cell.2020.03.052"},{"key":"4_CR233","doi-asserted-by":"crossref","unstructured":"Earle AJ, Kirby TJ, Fedorchak GR et al (2020) Mutant lamins cause nuclear envelope rupture and DNA damage in skeletal muscle cells. Nat Mater 19:464\u2013473","DOI":"10.1038\/s41563-019-0563-5"},{"key":"4_CR234","doi-asserted-by":"crossref","unstructured":"Chang W, Wang Y, Luxton GWG et al (2019) Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging. Proc Natl Acad Sci USA 116:3578\u20133583","DOI":"10.1073\/pnas.1809683116"},{"key":"4_CR235","doi-asserted-by":"crossref","unstructured":"Larrieu D, Britton S, Demir M et al (2014) Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science 344:527\u2013532","DOI":"10.1126\/science.1252651"},{"key":"4_CR236","doi-asserted-by":"crossref","unstructured":"Lee G-E, Byun J, Lee C-J, Cho Y-Y (2023) Molecular mechanisms for the regulation of nuclear membrane integrity. IJMS 24:15497","DOI":"10.3390\/ijms242015497"},{"key":"4_CR237","doi-asserted-by":"crossref","unstructured":"Balmus G, Larrieu D, Barros AC et al (2018) Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome. Nat Commun 9:1700","DOI":"10.1038\/s41467-018-03770-3"},{"key":"4_CR238","doi-asserted-by":"crossref","unstructured":"Gu\u00e9nantin A-C, Jebeniani I, Leschik J et al (2021) Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy. J Clin Invest 131(e136488):136488","DOI":"10.1172\/JCI136488"},{"key":"4_CR239","doi-asserted-by":"crossref","unstructured":"Veltrop RJA, Kukk MM, Topouzidou K et al (2024) From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy. Cell Commun Signal 22:197","DOI":"10.1186\/s12964-024-01546-5"},{"key":"4_CR240","doi-asserted-by":"crossref","unstructured":"Butin-Israeli V, Adam SA, Goldman AE, Goldman RD (2012) Nuclear lamin functions and disease. Trends Genet 28:464\u2013471","DOI":"10.1016\/j.tig.2012.06.001"},{"key":"4_CR241","doi-asserted-by":"crossref","unstructured":"Capo-chichi CD, Cai KQ, Smedberg J et al (2011) Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer. Chin J Cancer 30:415\u2013425","DOI":"10.5732\/cjc.010.10566"},{"key":"4_CR242","doi-asserted-by":"crossref","unstructured":"Zink D, Fischer AH, Nickerson JA (2004) Nuclear structure in cancer cells. Nat Rev Cancer 4:677\u2013687","DOI":"10.1038\/nrc1430"},{"key":"4_CR243","doi-asserted-by":"crossref","unstructured":"Sakthivel KM, Sehgal P (2016) A novel role of lamins from genetic disease to cancer biomarkers. Oncol Rev 10","DOI":"10.4081\/oncol.2016.309"},{"key":"4_CR244","doi-asserted-by":"crossref","unstructured":"Denais C, Lammerding J (2014) Nuclear mechanics in cancer. Adv Exp Med Biol 773:435\u2013470","DOI":"10.1007\/978-1-4899-8032-8_20"},{"key":"4_CR245","doi-asserted-by":"crossref","unstructured":"Tsai J-W, Chen Y, Kriegstein AR, Vallee RB (2005) LIS1 RNA interference blocks neural stem cell division, morphogenesis, and motility at multiple stages. J Cell Biol 170:935\u2013945","DOI":"10.1083\/jcb.200505166"},{"key":"4_CR246","doi-asserted-by":"crossref","unstructured":"Davidson PM, Sliz J, Isermann P et al (2015) Design of a microfluidic device to quantify dynamic intra-nuclear deformation during cell migration through confining environments. Integr Biol 7:1534\u20131546","DOI":"10.1039\/C5IB00200A"},{"key":"4_CR247","doi-asserted-by":"crossref","unstructured":"Lammerding J, Fong LG, Ji JY et al (2006) Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem 281:25768\u201325780","DOI":"10.1074\/jbc.M513511200"},{"key":"4_CR248","doi-asserted-by":"crossref","unstructured":"Pajerowski JD, Dahl KN, Zhong FL et al (2007) Physical plasticity of the nucleus in stem cell differentiation. Proc Natl Acad Sci USA 104:15619\u201315624","DOI":"10.1073\/pnas.0702576104"},{"key":"4_CR249","doi-asserted-by":"crossref","unstructured":"Ungricht R, Kutay U (2017) Mechanisms and functions of nuclear envelope remodelling. Nat Rev Mol Cell Biol 18:229\u2013245","DOI":"10.1038\/nrm.2016.153"},{"key":"4_CR250","unstructured":"Yabuki M, Miyake T, Doi Y et al (1999) Role of nuclear lamins in nuclear segmentation of human neutrophils. Physiol Chem Phys Med NMR 31:77\u201384"},{"key":"4_CR251","doi-asserted-by":"crossref","unstructured":"Kong L, Sch\u00e4fer G, Bu H et al (2012) Lamin A\/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K\/AKT\/PTEN pathway. Carcinogenesis 33:751\u2013759","DOI":"10.1093\/carcin\/bgs022"},{"key":"4_CR252","doi-asserted-by":"crossref","unstructured":"Skvortsov S, Sch\u00e4fer G, Stasyk T et al (2011) Proteomics profiling of microdissected low- and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker. J Proteome Res 10:259\u2013268","DOI":"10.1021\/pr100921j"},{"key":"4_CR253","doi-asserted-by":"crossref","unstructured":"Zuo L, Zhao H, Yang R et al (2018) Lamin A\/C might be involved in the EMT signalling pathway. Gene 663:51\u201364","DOI":"10.1016\/j.gene.2018.04.040"},{"key":"4_CR254","doi-asserted-by":"crossref","unstructured":"Wang Y, Wu R, Cho KR et al (2009) Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage. J Proteome Res 8:1452\u20131463","DOI":"10.1021\/pr800820z"},{"key":"4_CR255","doi-asserted-by":"crossref","unstructured":"Willis ND, Cox TR, Rahman-Casa\u00f1s SF et al (2008) Lamin A\/C is a risk biomarker in colorectal cancer. PLoS One 3:e2988","DOI":"10.1371\/journal.pone.0002988"},{"key":"4_CR256","doi-asserted-by":"crossref","unstructured":"Alhudiri IM, Nolan CC, Ellis IO et al (2019) Expression of Lamin A\/C in early-stage breast cancer and its prognostic value. Breast Cancer Res Treat 174:661\u2013668","DOI":"10.1007\/s10549-018-05092-w"},{"key":"4_CR257","doi-asserted-by":"crossref","unstructured":"Matsumoto A, Hieda M, Yokoyama Y et al (2015) Global loss of a nuclear lamina component, lamin A\/C, and LINC complex components SUN 1, SUN 2, and nesprin-2 in breast cancer. Cancer Med 4:1547\u20131557","DOI":"10.1002\/cam4.495"},{"key":"4_CR258","doi-asserted-by":"crossref","unstructured":"Wu Z, Wu L, Weng D et al (2009) Reduced expression of lamin A\/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. J Exp Clin Cancer Res 28:8","DOI":"10.1186\/1756-9966-28-8"},{"key":"4_CR259","unstructured":"Broers JL, Raymond Y, Rot MK et al (1993) Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am J Pathol 143:211\u2013220"},{"key":"4_CR260","doi-asserted-by":"crossref","unstructured":"Broers JLV, Ramaekers FCS (2014) The role of the nuclear lamina in cancer and apoptosis. In: Schirmer EC, de las Heras JI (eds) Cancer biology and the nuclear envelope. Springer, New York, NY, pp 27\u201348","DOI":"10.1007\/978-1-4899-8032-8_2"},{"key":"4_CR261","unstructured":"Kaufmann SH, Mabry M, Jasti R, Shaper JH (1991) Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines. Cancer Res 51:581\u2013586"},{"key":"4_CR262","doi-asserted-by":"crossref","unstructured":"Wang J, Kondo T, Nakazawa T et al (2019) Constitutional abnormality of nuclear membrane proteins in small cell lung carcinoma. Virchows Arch 475:407\u2013414","DOI":"10.1007\/s00428-019-02597-7"},{"key":"4_CR263","doi-asserted-by":"crossref","unstructured":"Capo-chichi CD, Aguida B, Chabi NW et al (2016) Lamin A\/C deficiency is an independent risk factor for cervical cancer. Cell Oncol (Dordr) 39:59\u201368","DOI":"10.1007\/s13402-015-0252-6"},{"key":"4_CR264","doi-asserted-by":"crossref","unstructured":"Saarinen I, Mirtti T, Seikkula H et al (2015) Differential predictive roles of A- and B-type nuclear Lamins in prostate cancer progression. PLoS One 10:e0140671","DOI":"10.1371\/journal.pone.0140671"},{"key":"4_CR265","doi-asserted-by":"crossref","unstructured":"Belt EJT, Fijneman RJA, van den Berg EG et al (2011) Loss of lamin A\/C expression in stage II and III colon cancer is associated with disease recurrence. Eur J Cancer 47:1837\u20131845","DOI":"10.1016\/j.ejca.2011.04.025"},{"key":"4_CR266","doi-asserted-by":"crossref","unstructured":"Moss SF, Krivosheyev V, de Souza A et al (1999) Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms. Gut 45:723\u2013729","DOI":"10.1136\/gut.45.5.723"},{"key":"4_CR267","doi-asserted-by":"crossref","unstructured":"Setti Boubaker N, Gurtner A, Trabelsi N et al (2021) The diagnostic applicability of A-type Lamin in non-muscle invasive bladder cancer. Ann Diagn Pathol 54:151808","DOI":"10.1016\/j.anndiagpath.2021.151808"},{"key":"4_CR268","doi-asserted-by":"crossref","unstructured":"Kaspi E, Frankel D, Guinde J et al (2017) Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status. PLoS One 12:e0183136","DOI":"10.1371\/journal.pone.0183136"},{"key":"4_CR269","doi-asserted-by":"crossref","unstructured":"Cicchillitti L, Corrado G, Carosi M et al (2017) Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer. Oncotarget 8:7935\u20137945","DOI":"10.18632\/oncotarget.13854"},{"key":"4_CR270","doi-asserted-by":"crossref","unstructured":"Gong G, Chen P, Li L et al (2015) Loss of lamin A but not lamin C expression in epithelial ovarian cancer cells is associated with metastasis and poor prognosis. Pathol Res Pract 211:175\u2013182","DOI":"10.1016\/j.prp.2014.11.008"},{"key":"4_CR271","doi-asserted-by":"crossref","unstructured":"Aljada A, Doria J, Saleh AM et al (2016) Altered Lamin A\/C splice variant expression as a possible diagnostic marker in breast cancer. Cell Oncol 39:161\u2013174","DOI":"10.1007\/s13402-015-0265-1"},{"key":"4_CR272","doi-asserted-by":"crossref","unstructured":"Sengupta D, Mukhopadhyay A, Sengupta K (2023) Elevated levels of Lamin A promote HR and NHEJ-mediated repair mechanisms in high-grade ovarian serous carcinoma cell line. Cells 12:757","DOI":"10.3390\/cells12050757"},{"key":"4_CR273","doi-asserted-by":"crossref","unstructured":"Bell ES, Shah P, Zuela-Sopilniak N et al (2022) Low lamin A levels enhance confined cell migration and metastatic capacity in breast cancer. Oncogene 41:4211\u20134230","DOI":"10.1038\/s41388-022-02420-9"},{"key":"4_CR274","doi-asserted-by":"crossref","unstructured":"Sun S, Xu MZ, Poon RT et al (2010) Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients. J Proteome Res 9:70\u201378","DOI":"10.1021\/pr9002118"},{"key":"4_CR275","doi-asserted-by":"crossref","unstructured":"Yang Y, Xiao W, Liu R et al (2022) A Lamin family-based signature predicts prognosis and immunotherapy response in hepatocellular carcinoma. J Immunol Res 2022:1\u201323","DOI":"10.1155\/2022\/4983532"},{"key":"4_CR276","unstructured":"Hong J-H, Liang S-T, Wang AS-S et al (2022) LMNB1, a potential marker for early prostate cancer progression. Am J Cancer Res 12:3390\u20133404"},{"key":"4_CR277","doi-asserted-by":"crossref","unstructured":"Luo F, Han J, Chen Y et al (2021) Lamin B1 promotes tumor progression and metastasis in primary prostate cancer patients. Future Oncol 17:663\u2013673","DOI":"10.2217\/fon-2020-0825"},{"key":"4_CR278","doi-asserted-by":"crossref","unstructured":"Huang Y, Zhang L, Liu T, Liang E (2023) LMNB1 targets FOXD1 to promote progression of prostate cancer. Exp Ther Med 26:513","DOI":"10.3892\/etm.2023.12212"},{"key":"4_CR279","doi-asserted-by":"crossref","unstructured":"Saleh T, Alhesa A, El-Sadoni M et al (2022) The expression of the senescence-associated biomarker Lamin B1 in human breast cancer. Diagnostics 12:609","DOI":"10.3390\/diagnostics12030609"},{"key":"4_CR280","doi-asserted-by":"crossref","unstructured":"Wazir U, Ahmed M, Bridger J et al (2013) The clinicopathological significance of lamin A\/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer. Cell Mol Biol Lett 18:595","DOI":"10.2478\/s11658-013-0109-9"},{"key":"4_CR281","doi-asserted-by":"crossref","unstructured":"Dong J, Ru Y, Zhai L et al (2023) LMNB1 deletion in ovarian cancer inhibits the proliferation and metastasis of tumor cells through PI3K\/Akt pathway. Exp Cell Res 426:113573","DOI":"10.1016\/j.yexcr.2023.113573"},{"key":"4_CR282","doi-asserted-by":"crossref","unstructured":"Zhao C-C, Chen J, Zhang L-Y et al (2021) Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis. Biosci Rep 41:BSR20203874","DOI":"10.1042\/BSR20203874"},{"key":"4_CR283","doi-asserted-by":"crossref","unstructured":"Yu ZY, Jiang XY, Zhao RR et al (2021) Lamin B1 deficiency promotes malignancy and predicts poor prognosis in gastric cancer. Neoplasma 67:1303\u20131313","DOI":"10.4149\/neo_2020_200109N33"},{"key":"4_CR284","doi-asserted-by":"crossref","unstructured":"Dong C-H, Jiang T, Yin H et al (2021) LMNB2 promotes the progression of colorectal cancer by silencing p21 expression. Cell Death Dis 12:331","DOI":"10.1038\/s41419-021-03602-1"},{"key":"4_CR285","doi-asserted-by":"crossref","unstructured":"Chen Y, Chen J, Shi Y et al (2024) Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma. Endocr Relat Cancer 31(3):e230178","DOI":"10.1530\/ERC-23-0178"},{"key":"4_CR286","doi-asserted-by":"crossref","unstructured":"Li L, Du Y, Kong X et al (2013) Lamin B1 is a novel therapeutic target of betulinic acid in pancreatic cancer. Clin Cancer Res 19:4651\u20134661","DOI":"10.1158\/1078-0432.CCR-12-3630"},{"key":"4_CR287","doi-asserted-by":"crossref","unstructured":"Ji J, Li H, Chen J, Wang W (2022) Lamin B2 contributes to the proliferation of bladder cancer cells via activating the expression of cell division cycle-associated protein 3. Int J Mol Med 50:111","DOI":"10.3892\/ijmm.2022.5168"},{"key":"4_CR288","unstructured":"Wang J, Ma M, Liu X (2022) Lamins B2 promotes esophageal cancer by stimulating proliferation and inhibiting apoptosis. Ann Clin Lab Sci 52:202\u2013212"},{"key":"4_CR289","doi-asserted-by":"crossref","unstructured":"Jia Y, Vong JS-L, Asafova A et al (2019) Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET. J Exp Med 216:1377\u20131395","DOI":"10.1084\/jem.20181394"},{"key":"4_CR290","unstructured":"Machiels BM, Broers JL, Raymond Y et al (1995) Abnormal A-type lamin organization in a human lung carcinoma cell line. Eur J Cell Biol 67:328\u2013335"},{"key":"4_CR291","doi-asserted-by":"crossref","unstructured":"Zhang M-Y, Han Y-C, Han Q et al (2020) Lamin B2 promotes the malignant phenotype of non-small cell lung cancer cells by upregulating dimethylation of histone 3 lysine 9. Exp Cell Res 393:112090","DOI":"10.1016\/j.yexcr.2020.112090"},{"key":"4_CR292","doi-asserted-by":"crossref","unstructured":"Stadelmann B, Khandjian E, Hirt A et al (1990) Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin\u2019s lymphoma cells. Leuk Res 14:815\u2013821","DOI":"10.1016\/0145-2126(90)90076-L"},{"key":"4_CR293","doi-asserted-by":"crossref","unstructured":"Agrelo R, Setien F, Espada J et al (2005) Inactivation of the Lamin A\/C gene by CpG Island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. JCO 23:3940\u20133947","DOI":"10.1200\/JCO.2005.11.650"},{"key":"4_CR294","doi-asserted-by":"crossref","unstructured":"Wu G, Tian Q, Liu J et al (2022) Comprehensive analysis of expression and prognosis for LMNB family genes in human sarcoma. Medicine 101","DOI":"10.1097\/MD.0000000000028933"},{"key":"4_CR295","doi-asserted-by":"crossref","unstructured":"Evangelisti C, Paganelli F, Giuntini G et al (2020) Lamin A and prelamin A counteract migration of osteosarcoma cells. Cells 9:774","DOI":"10.3390\/cells9030774"},{"key":"4_CR296","doi-asserted-by":"crossref","unstructured":"Chiarini F, Paganelli F, Balestra T et al (2022) Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma. Cell Death Dis 13:346","DOI":"10.1038\/s41419-022-04729-5"},{"key":"4_CR297","doi-asserted-by":"crossref","unstructured":"Doebele RC, Davis LE, Vaishnavi A et al (2015) An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the tropomyosin-related kinase inhibitor LOXO-101. Cancer Discov 5:1049\u20131057","DOI":"10.1158\/2159-8290.CD-15-0443"},{"key":"4_CR298","doi-asserted-by":"crossref","unstructured":"Haller F, Knopf J, Ackermann A et al (2016) Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic\/haemangiopericytic pattern. J Pathol 238:700\u2013710","DOI":"10.1002\/path.4701"},{"key":"4_CR299","doi-asserted-by":"crossref","unstructured":"Pei S, Wang X, Wang X et al (2022) Aberrant nuclear lamina contributes to the malignancy of human gliomas. J Genet Genomics 49:132\u2013144","DOI":"10.1016\/j.jgg.2021.08.013"},{"key":"4_CR300","doi-asserted-by":"crossref","unstructured":"Gatti G, Vilardo L, Musa C et al (2021) Role of Lamin A\/C as candidate biomarker of aggressiveness and tumorigenicity in glioblastoma multiforme. Biomedicine 9:1343","DOI":"10.3390\/biomedicines9101343"},{"key":"4_CR301","doi-asserted-by":"crossref","unstructured":"Maresca G, Natoli M, Nardella M et al (2012) LMNA knock-down affects differentiation and progression of human neuroblastoma cells. PLoS One 7:e45513","DOI":"10.1371\/journal.pone.0045513"},{"key":"4_CR302","doi-asserted-by":"crossref","unstructured":"Rauschert I, Aldunate F, Preussner J et al (2017) Promoter hypermethylation as a mechanism for Lamin A\/C silencing in a subset of neuroblastoma cells. PLoS One 12:e0175953","DOI":"10.1371\/journal.pone.0175953"},{"key":"4_CR303","doi-asserted-by":"crossref","unstructured":"Roncato F, Regev O, Feigelson SW et al (2021) Reduced Lamin A\/C does not facilitate cancer cell transendothelial migration but compromises lung metastasis. Cancers (Basel) 13:2383","DOI":"10.3390\/cancers13102383"},{"key":"4_CR304","doi-asserted-by":"crossref","unstructured":"L\u00e4mmerhirt L, Kappelmann-Fenzl M, Fischer S et al (2022) Knockdown of lamin B1 and the corresponding lamin B receptor leads to changes in heterochromatin state and senescence induction in malignant melanoma. Cells 11:2154","DOI":"10.3390\/cells11142154"}],"container-title":["Subcellular Biochemistry","Lamins in Genome Organization and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-00537-3_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:29:12Z","timestamp":1778941752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-00537-3_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783032005366","9783032005373"],"references-count":304,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-00537-3_4","relation":{},"ISSN":["0306-0225","2542-8810"],"issn-type":[{"value":"0306-0225","type":"print"},{"value":"2542-8810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"1 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}